Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs (2009)
- Autores:
- Autores USP: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidade: FCF
- DOI: 10.2217/pgs.09.18
- Assuntos: LIPOPROTEÍNAS LDL; HIPERCOLESTEROLEMIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Pharmacogenomics
- ISSN: 1462-2416
- Volume/Número/Paginação/Ano: v. 10, n. 6, p. 1007-1016, 2009
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
RODRIGUES, Alice Cristina e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, v. 10, n. 6, p. 1007-1016, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.18. Acesso em: 23 abr. 2024. -
APA
Rodrigues, A. C., Hirata, M. H., & Hirata, R. D. C. (2009). Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, 10( 6), 1007-1016. doi:10.2217/pgs.09.18 -
NLM
Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 abr. 23 ] Available from: https://doi.org/10.2217/pgs.09.18 -
Vancouver
Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 abr. 23 ] Available from: https://doi.org/10.2217/pgs.09.18 - Could SNPs predict Cisplatin toxicity?
- Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis
- Bases farmacogenômicas da resistência medicamentosa
- Inclusion body formation in escherichia coli: a procedure for optimizing production of soluble protein in application to human interferon alpha receptor
- Expression of three polypeptide kfragments of human interferon alpha receptor cloning flexibility and optimization of expression efficienty
- Reconhecimento do receptor recombinante de ifn 'ALFA' / 'BETA' humano por anticorpos policlonais de coelho
- Human interferon alpha receptor: identification of the regeion involved in binding to interferon alpha b
- Cloning and expression of treponema pallidium 47 kda antigen in e. Coli dh5 'ALPHA'
- Estratégia de extração de DNA de manchas sanguíneas para testes forensicos por PCR
- Cloning of a fragment of the 5 noncoding region of HCV genome for using as an internal control in PCR
Informações sobre o DOI: 10.2217/pgs.09.18 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
